作者: R Bendardaf , H Lamlum , R Ristamäki , E Korkeila , K Syrjänen
DOI: 10.1159/000107417
关键词: Predictive factor 、 Fluorouracil 、 Oncology 、 Internal medicine 、 Chemotherapy 、 Advanced colorectal cancer 、 In patient 、 DNA mismatch repair 、 Irinotecan 、 Medicine 、 Metastasis
摘要: Background and Aims: To determine the association between DNA mismatch repair (MMR) protein expression response to chemotherapy in patients with advanced colorectal cancer (CRC)